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secretory machinery. Furthermore, we tested the influence of 
Abstract Organelles of the early protein secretion pathway brefeldin A (BFA), cycloheximide (CHI), and nocodazole on 
(ER, Golgi) are involved in biosynthesis and intracellular migra- sphingolipid synthesis and intracellular transport. The toxin 
tion of the yeast ~phingolipids, inositolphosphorylceramide (IPC), BFA dramatically alters structure and function of organelles of 
mannosylinositoiphosphorylceramide (MIPC), and mannosyl- 
diinositolphosphorylceramide (M(IP)2C). Cycloheximide and the secretory pathway in mammalian cells [11,12]. In Saccharo- 
nocodazole neither block biosynthesis of sphingolipids, nor ER to myces cerevisiae BFA has be shown to be active only in strains 
Golgi transport of IPC. In contrast, treatment of yeast cells with with a defect in ergosterol biosynthesis, e.g. the erg6 mutant 
brefeldin A, which affects integrity of the Golgi, decreases forma- [ 13]. CHI blocks synthesis of proteins on cytosolic ribosomes, 
tion of IPC and MIPC. Interruption of late steps of protein but not the flux of secretory vesicles [14]. However, Ayscough 
secretion (Golgi to plasma membrane transport) in temperature- and Warren [15] showed that treatment of Schizosaccharomyces 
sensitive secretory mutants prevents sphingolipids from being pombe with CHI resulted in a lack of recognizable Golgi stacks. 
transported to the cell periphery. Nocodazole causes disruption of microtubules [16] and may 
thus influence the protein flux through the secretory pathway. 
Key words. Sphingolipid; Lipid transport; Protein secretion; In this paper we demonstrate, that BFA affects transport of 
Plasma membrane; Saccharomyces cerevisiae 
IPC between the endoplasmic reticulum and Golgi. In contrast, 
neither nocodazole nor CHI have an influence on sphingolipid 
biosynthesis and translocation i yeast. 
1. Introduction 
2. Materials and methods 
In yeast as in higher eukaryotic ells sphingolipids are essen- 
tial membrane components. The yeast, Saccharomyces cerevis- 2.1. Yeast strains and culture condition 
iae, contains three major classes of sphingolipids, namely inos- The wild-type yeast strain Saccharomyces revisiae X2180-1A (a, 
SUC2, mal, gal2, CUP1), the mutant strain Saccharomyces revisiae 
itolphosphorylceramide (IPC), mannosylinositolphosphorylcer- erg6 FKY 213 (c~, erg-A, ura3 1, leu2-3,-112, his3 11,-15, trpl 1, 
amide (MIPC), and mannosyl-diinositolphosphorylceramide ade2-1, CanR) and the corresponding wild-type strain FKY 131 (c~, 
(M(IP)2C). The role of these lipids in cell growth and viability ura3-1, leu2-3,-112, his3-11,-15, trpl 1, ade2-1, CanR) (provided by 
is still obscure. They are thought o be involved in the modula- F. Kepes), and the temperature-sensitive secretory mutants Saccharo- 
myces cerevisiae s cl, sec6 and secl4 (provided by R. Schekman) were 
tion of plasma membrane H+-ATPase activity [1], membrane used throughout this study. Cells were grown aerobically in 0.5- or 
signalling [2], regulation of phospholipid biosynthesis [3], and 2-liter flasks either on YPD medium containing 3% glucose, 1% yeast 
anchoring of cell surface glycoproteins [4]. IPC is synthesized extract (Difco), and 2% peptone (Difco), or on inositol-free medium 
in the endoplasmic reticulum [5]. Mannosylation and further [17]. Wild-type strains and the erg6 mutant were cultivated at 30°C, 
addition of inositolphosphate, l ading to the formation of temperature-sensitive secretory mutants at 24°C, and shifted to 37°C 
to induce the secretion block. 
M(IP)C and M(IP)2C, occur in the Golgi. Puoti et al. [6] and 
Hechtberger et al. [7] reported that temperature-sensitive yeast 2.2. Labelling of total cellular sphingolipids with [3H]inositol 
secretory mutants [8], blocked in early steps of the secretory Cells were grown in inositol-free medium for 16 h, transferred tonew 
pathway of proteins, are unable to synthesize a subclass of IPC, medium, and adjusted to an A600 of l0 in a volume of 0.5 ml. Preincu- 
bation of the erg6 mutant and the corresponding wild-type strain with 
MIPC and M(IP)2C at the non-permissive t mperature. This BFA (Sigma Chemical Co., St. Louis, MO; final concentration 100 
observation supported the notion that sphingolipids are trans- /lg/ml; stock solution in ethanol) was carried out at 30°C for 90 min. 
ported from the ER to the Golgi via the secretory pathway of Treatment of the wild-type strain Saccharomyces revisiae X2180-1A 
proteins, with CHI (Boehringer Mannheim GmbH, Germany; final concentra- 
In yeast cells the major location of mannosylated sphingolip- tion 23 ,ug/ml; stock solution in water) or nocodazole (Sigma Chemical 
Co., St. Louis, MO; final concentration 15/zg/ml; stock solution in 
ids is the plasma membrane [9,10]. The fact that IPC, MIPC, DMSO) was performed at 30°C for 2 h. Control cells were treated with 
and M(IP)2C are also present in secretory vesicles [10] gave the corresponding volume of the respective solvent. Then, cells were 
raise to the idea that also late steps of sphingolipid transport labeled for 3 h with 10/zCi [3H]inositol (spec.act. 20 Ci/mmol). After 
(Golgi to plasma membrane) occur via the secretory pathway the labelling period NaN 3 (final concentration 10mM) was added, cells 
were harvested by centrifugation, suspended in3 ml chloroform/meth- 
of proteins. In order to address this question we performed anol/pyridine/water (60:30:1:6; per vol.), and frozen in liquid nitro- 
experiments using late secretory mutants (secl, sec6, and gen. Glass beads (1 ml; 0.3-0.4 mm diameter) were added, and cells 
secl4) and demonstrated, that appearance of IPC, MIPC, and were disintegrated at room temperature by vigorous haking on an 
M(IP)2C in the plasma membrane depends on an intact protein EVAPO-MIX (Buchler Instruments, Fort Lee, NJ) for 10 min. After 
two hours extraction at room temperature, glass beads and cell debris 
were removed by centrifugation a d reextracted. The combined super- 
*Corresponding author. Fax: (43) (316) 810 599. natants containing the inositol-labeled lipids (phosphatidylinositol, 
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sphingolipids) were taken to dryness. Lipids were dissolved in 0.5 ml 
chloroform/methanol/water (16: 16:5; per vol.). PI 
2.3. Labelling of secretory mutants with [3H]inositol and isolation of IPC 1 
the plasma membrane IPC 2 
Yeast secretory mutants were grown on YPD medium in 2 liter flasks MIPC 
at 24°C for 16 h. Cells were harvested and resuspended in 1 liter 
inositol-free medium. One half of the culture was further incubated at 
24°C, the other half at 37°C (induction of the secretion block) for two 
hours. Then, cells were labeled with [3H]inositol (200 ¢tCi per flask; M(IP)2C 
spec. act. 20 Ci/mmol) for 2 h. Metabolism was stopped with NaN 3 
(final concentration 10 mM), and the plasma membrane was isolated 
by the method of Serrano [18]. Inositol-containing lipids were extracted 
with chloroform/methanol/pyridine/water (60:30:1:6; per vol.) at 
57°C for 16 h. Membrane remnants were removed by filtration, and the 
solvent was removed under a stream of nitrogen. Lipids were dissolved origin 
in 1 ml chloroform/methanol/water (16:16:5; per vol.), and mild sap- 
onification was carried out with 1 ml 0.2 M NaOH in methanol at 30°C 
+ - -  4 -  
for 1 h. Then, 1 ml of 0.5 M EDTA was added, and samples were 
neutralized with 200 ,ul of 1 M acetic acid. Unsaponified lipids (among CHI nocodazole 
them sphingolipids) were extracted with 1 ml chloroform. Samples were Fig. 2. Cycloheximide and nocodazole do not influence synthesis and 
taken to dryness and resuspended in 0.5 ml chloroform/methanol/water transport of yeast sphingolipids. Treatment of the wild-type yeast strain 
(16:16:5; per vol.). Saccharomyces cerevisiae X-2180 with cycloheximide (CHI) and noco- 
dazole, and labelling with [3H]inositol were carried out as described in 
2.4. Labelling oflipids with [~H]inositol in vitro section 2. The autoradiogram shows the pattern of inositol-labeled 
A microsomal fraction (40,000 x g membrane pellet) was isolated lipids in treated (+) and untreated (-) cells after thin-layer chromato- 
from Saccharomyces cerevisiae X2180 1A as described elsewhere [19] .  graphic separation. 
Microsomes (200 ,ug membrane protein) were incubated in 0.5 ml 50 
mM Tris-HCl (pH 7.0), 5 mM MgCI2, 1 mM PMSF, either in the 
absence or presence of BFA (final concentration 73,ug/ml) for 30 min 
at 30°C. Then, samples were labeled with 5/ICi of [3H]inositol (spec.act. 
20 Ci/mmol) for 3 h. Lipids were extracted with 6 ml chloroform/ 
methanol/pyridine/water (60:30:1:6; per vol.) at 57°C for 16 hours, were raised in rabbits as described elsewhere [23]. Immunoreactive 
proteins were detected by ELISA using peroxidase-conjugated goat 
Membrane remnants were removed by filtration, extracts were taken anti-rabbit IgG as secondary antibodies. 
to dryness, and lipids were dissolved in 0.5 ml chloroform/methanol/ 
water (16: 16: 5; per vol.). 
2.5. Analytical procedures 3. Results 
Thin-layer chromatography of sphingolipids was carried out on 
Polygram Sil G plates (Macherey-Nagel) using chloroform/methanol/ Brefeldin A (BFA), which is known to cause disassembly of 
4.2 M NH3 (9: 7: 2; per vol.) as a developing solvent. Plates containing the Golgi in mammal ian cells [11,12] is not able to penetrate the 
radioactive lipids were scanned on an Automatic TLC-Linear Analyzer plasma membrane of wild-type yeast cells. Mutants  of Sac- 
(Berthold). For autoradiography plates were sprayed with Amplify 
(Amersham) and exposed to X-ray films for several days at -70°C. charomyces cerevisiae defective in ergosterol biosynthesis with 
X-Ray films were scanned on a Dual Wavelenght Chromato Scanner an altered permeability of the plasma membrane can incorpo- 
CS-930 (Shimadzu). rate BFA thus allowing studies comparable to those described 
Proteins were quantified by the method of Lowry et al. [20]. SDS- for higher eukaryotes. Treatment with BFA caused growth 
PAGE was carried out as described by Laemmli [21]. Western blot inhibit ion of the erg6 mutant  strain, whereas the corresponding 
analysis was performed by the method of Haid and Suissa [22]. Anti- 
serum against yeast plasma membrane ATPase was a gift of R. Serrano, wild-type yeast strain was not affected (data not shown). Incor- 
Valencia, Spain. Antibodies against other organelle specific proteins poration of [3H]inositol into lipids (see section 2) was not af- 
fected by BFA, but the amount  of label in IPC and MIPC was 
90- dramatically reduced in the presence of the drug (Fig. 1). Con- 
comitantly, [3H]inositol accumulated in phosphatidylinositol,  
8o- which is known to act as a precursor of IPC [24]. This effect 
70- could only be observed in the erg6 mutant  strain, but not in 
60 • M( IP)2C wild-type cells. Similar amounts of radioactivity were detected 
0~ 50- • mcc in M(IP)2C of cells grown in the presence or absence of BFA. 
The decreased 3 amount  of [ H]inositol detected in IPC of erg6 E 4o- D~ 
o cells treated with BFA could be attr ibuted either to an inhibi- 
30- [] ~ tion of IPC systhesis caused by the drug, or to a disturbance 
~ of transport- l inked metabolic onversion. The former possibil- 
10- ~i~ i~ ity was ruled out by an in vitro assay (see section 2) measuring 
3 incorporat ion of [ H]inositol into phosphatidyl inositol and IPC 
eros +BFA eros -BFA Wt *BFA Wt -BFA using 40,000 x g microsomes as an enzyme source. In the pres- 
Fig. 1. Influence of BFA on synthesis and transport of yeast sphingol- ence as well as in the absence of BFA 85 + 4% of the label were 
ipids. The BFA-sensitive yeast strain Saecharomyces cerevisiae rg6  incorporated into phosphatidylinositol,  and 15 + 4% into IPC. 
(erg6) and the corresponding BFA-insensitive wild-type (Wt) were la- In order to test if an intact eytoskeleton and ongoing protein 
beled with [3H]inositol for 3 h as described in section 2. The distribution 
of the label among inositol-containinglipids in the presence (+BFA) or synthesis are required for passage of yeast sphingolipids 
absence of BFA (-BFA) was calculated in % cpm. through the early stages of the secretory pathway, experiments 
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80000 strate concentration for the enzyme catalyzing the last step in 
this sequence leading to the formation of M(IP)2C. 
5oooo- Cycloheximide (CHI) blocks the synthesis of proteins, but "F: 
= ~ - -  the flux of secretory vesicles is not affected [14]. Neither synthe- 
40000 
t~ • M(IP)2C sis nor transport of sphingolipids are inhibited by treatment of 
..o ~ 30000- : ............ - ~  • MIFt3 yeast with CHI (see Fig. 2). These results indicate that sphingo- 
v !::~i:; ~ lipid synthesis and transport are not directly linked to protein 
20000- ::iiiii! [] m synthesis, but leaves us with the possibility of the migration of 
g ~}ii: sphingolipids via secretory pathway. 
~,~i Microtubules are thought o be involved in polarized move- 
0 , , .~</ ment of vesicles in animal cells [27], but they do not directly 
X2180 24°C X2180 37°C see1 24°C see1 37°C govern the growth dependent polarization in the yeast Sac- 
Fig. 3. Migration of sphingolipids tothe plasma membrane is blocked charomyces cerevisiae [16]. Our results demonstrating that 
in the late secretory mutant Saccharomyces revisiae s cl under non- nocodazole has no influence on sphingolipid synthesis and 
permissive conditions. The temperature-sensitive mutant strain Sac- 
charomyces erevisiae s cl and the corresponding wild-type strain Sac-  transport (see Fig. 2) is in line with the observations mentioned 
charomyces cerevisiae X2180 were grown at the permissive (24°C) and above. 
non-permissive (37°C) temperature, respectively. Cells were labeled High concentrations of sphingolipids in secretory vesicles, 
with [3H]inositol, and plasma membrane was isolated as described in which serve as transport vehicles for proteins from the Golgi 
the section 2. Labeled sphingolipids of the plasma membrane were 
to the plasma membrane, served as an indication that also late separated by thin-layer chromatography, visualized by autoradiogra- 
phy, and quantified by optical scanning. Values are expressed as arbi- steps of the migration of sphingolipids to the cell periphery may 
trary units (peak area), depend on a functional secretory machinery [10]. This idea was 
confirmed by the finding, that a temperature-dependent block 
in the late secretory pathway of the yeast (secl mutation) pre- 
vents sphingolipids from reaching the plasma membrane (see 
with the microtubules-disrupting drug nocodazole and with Fig. 3). These results complete the view that sphingolipid trans- 
cycloheximide (CHI) were carried out. Neither nocodazole nor port and protein secretion are linked processes in yeast. 
CHI had a marked influence on sphingolipid synthesis and 
transport-linked conversion of IPC to M(IP)C and M(IP)2C Acknowledgements: The authors are grateful to R. Schekman and F. 
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